217 related articles for article (PubMed ID: 35272503)
1. Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study.
Schjødt I; Johnsen SP; Strömberg A; DeVore AD; Valentin JB; Løgstrup BB
Circ Cardiovasc Qual Outcomes; 2022 Apr; 15(4):e007973. PubMed ID: 35272503
[TBL] [Abstract][Full Text] [Related]
2. Inequalities in heart failure care in a tax-financed universal healthcare system: a nationwide population-based cohort study.
Schjødt I; Johnsen SP; Strömberg A; Valentin JB; Løgstrup BB
ESC Heart Fail; 2020 Oct; 7(5):3095-3108. PubMed ID: 32767628
[TBL] [Abstract][Full Text] [Related]
3. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
4. Association between process performance measures and 1-year mortality among patients with incident heart failure: a Danish nationwide study.
Nakano A; Vinter N; Egstrup K; Svendsen ML; Schjødt I; Johnsen SP
Eur Heart J Qual Care Clin Outcomes; 2019 Jan; 5(1):28-34. PubMed ID: 30204858
[TBL] [Abstract][Full Text] [Related]
5. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
[TBL] [Abstract][Full Text] [Related]
6. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
[TBL] [Abstract][Full Text] [Related]
7. Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide Study.
Garred CH; Zahir D; Butt JH; Ravn PB; Bruhn J; Gislason GH; Fosbøl EL; Torp-Pedersen C; Petrie MC; McMurray JJV; Køber L; Schou M
J Am Heart Assoc; 2022 Oct; 11(19):e026187. PubMed ID: 36172925
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
9. Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study.
Sepehrvand N; Nabipoor M; Youngson E; McAlister FA; Ezekowitz JA
J Card Fail; 2023 May; 29(5):719-729. PubMed ID: 36754252
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.
Harikrishnan S; Sanjay G; Anees T; Viswanathan S; Vijayaraghavan G; Bahuleyan CG; Sreedharan M; Biju R; Nair T; Suresh K; Rao AC; Dalus D; Huffman MD; Jeemon P;
Eur J Heart Fail; 2015 Aug; 17(8):794-800. PubMed ID: 26011246
[TBL] [Abstract][Full Text] [Related]
11. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
14. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
15. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
[TBL] [Abstract][Full Text] [Related]
16. Impact of Socioeconomic Status on Mortality and Readmission in Patients With Heart Failure With Reduced Ejection Fraction: The ARIC Study.
Mathews L; Ding N; Mok Y; Shin JI; Crews DC; Rosamond WD; Newton AK; Chang PP; Ndumele CE; Coresh J; Matsushita K
J Am Heart Assoc; 2022 Sep; 11(18):e024057. PubMed ID: 36102228
[TBL] [Abstract][Full Text] [Related]
17. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC
Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697
[TBL] [Abstract][Full Text] [Related]
18. Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure.
Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Kim JJ; Oh BH
JACC Heart Fail; 2017 Nov; 5(11):810-819. PubMed ID: 29096790
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
[TBL] [Abstract][Full Text] [Related]
20. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
